Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

Topical vitamin D is effective in treating vitiligo with few side effects.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

Early regulatory T cells are crucial for normal skin pigmentation.

Patients with RASopathies have a higher risk of autoimmune disorders and should be routinely screened.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Mint water extract boosts protective enzymes in skin cells.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Catalytic antibodies are early indicators and active participants in the development of systemic lupus erythematosus.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Hair follicles prevent NK cell attacks to avoid hair loss.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

NK cells play a role in skin diseases like eczema and psoriasis.